U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
180571180571Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.CompletedNo Results AvailableUrinary Incontinence, StressDrug: duloxetine|Drug: placebohttps://ClinicalTrials.gov/show/NCT00190814
180572180572Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric CarcinomaCompletedNo Results AvailableGastrointestinal NeoplasmsDrug: pemetrexed|Drug: cisplatinhttps://ClinicalTrials.gov/show/NCT00190801
180573180573Extended Therapy of Drotrecogin Alfa (Activated) 4 vs 7 Days InfusionCompletedNo Results AvailableSepsis|HypotensionDrug: Drotrecogin Alfa (Activated)|Drug: placebohttps://ClinicalTrials.gov/show/NCT00190788
180574180574A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedHas ResultsAttention Deficit Hyperactivity DisorderDrug: Atomoxetine Hydrochloride|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00190775
180575180575A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of MesotheliomaCompletedNo Results AvailableMesotheliomaDrug: Pemetrexedhttps://ClinicalTrials.gov/show/NCT00190762
180576180576Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective DisorderCompletedHas ResultsSchizophrenia|Schizoaffective DisorderDrug: olanzapine|Drug: risperidonehttps://ClinicalTrials.gov/show/NCT00190749
180577180577Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months)CompletedNo Results AvailableADHDDrug: Atomoxetine Hydrochloride|Drug: placebohttps://ClinicalTrials.gov/show/NCT00190736
180578180578A Study of LY317615 in Patients With Brain TumorsCompletedNo Results AvailableMalignant GliomaDrug: Enzastaurinhttps://ClinicalTrials.gov/show/NCT00190723
180579180579A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung CancerCompletedNo Results AvailableNon-Small Cell Lung CancerDrug: Gemcitabine|Drug: Carboplatinhttps://ClinicalTrials.gov/show/NCT00190710
180580180580A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue TreatmentCompletedNo Results AvailableBreast Cancer|Endometrial Cancer|Ovarian CancerDrug: arzoxifenehttps://ClinicalTrials.gov/show/NCT00190697
180581180581Long-Term, Open Label Atomoxetine StudyCompletedHas ResultsAttention Deficit Hyperactivity DisorderDrug: atomoxetinehttps://ClinicalTrials.gov/show/NCT00190684
180582180582A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer PatientsCompletedHas ResultsBreast CancerDrug: pemetrexed|Drug: cyclophosphamide|Drug: pemetrexedhttps://ClinicalTrials.gov/show/NCT00190671
180583180583Somatropin Treatment in Patients With SHOX Deficiency and Turner SyndromeCompletedNo Results AvailableFailure to ThriveDrug: Somatropin (rDNA origin) for injectionhttps://ClinicalTrials.gov/show/NCT00190658
180584180584To Evaluate the Safety of Duloxetine in Patients With Stress Urinary IncontinenceCompletedNo Results AvailableStress Urinary IncontinenceDrug: Duloxetinehttps://ClinicalTrials.gov/show/NCT00190645
180585180585To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary IncontinenceCompletedNo Results AvailableStress Urinary IncontinenceDrug: Duloxetinehttps://ClinicalTrials.gov/show/NCT00190632
180586180586Efficacy and Safety of DuloxetineCompletedNo Results AvailableUrinary Stress IncontinenceDrug: Duloxetine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00190619
180587180587Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary IncontinenceCompletedNo Results AvailableUrinary Stress IncontinenceDrug: Duloxetine|Procedure: Pelvic Floor Muscle Training (PFMT)|Procedure: Imitation PFMT|Drug: placebohttps://ClinicalTrials.gov/show/NCT00190606
180588180588Raloxifene Use for The HeartCompletedNo Results AvailableCardiovascular Diseases|Breast NeoplasmsDrug: raloxifene|Drug: placebohttps://ClinicalTrials.gov/show/NCT00190593
180589180589Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular DiseaseCompletedNo Results AvailableChronic Kidney Disease|HypertensionDrug: valsartan|Drug: Conventional antihypertensive drugshttps://ClinicalTrials.gov/show/NCT00190580
180590180590Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress IncontinenceCompletedNo Results AvailableUrinary Stress IncontinenceDrug: duloxetine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00190567
180591180591A Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell CarcinomaTerminatedNo Results AvailableEsophageal Neoplasms|Carcinoma, Squamous CellDrug: Surgery +(Cisplatin 80 mg/㎡+5FU 800mg/㎡×5days)×2|Drug: (Cisplatin 80 mg/㎡+5FU 800mg/㎡×5days)×2+Surgeryhttps://ClinicalTrials.gov/show/NCT00190554
180592180592Mesorectal Excision (ME) Versus ME With Lateral Node Dissection for Stage II, III Lower Rectal Cancer (JCOG0212)RecruitingNo Results AvailableRectal NeoplasmsProcedure: Mesorectal excision with lateral lymph node dissection|Procedure: Mesorectal excision without lateral lymph node excisionhttps://ClinicalTrials.gov/show/NCT00190541
180593180593A Trial of Neoadjuvant Chemotherapy + Surgery vs. Surgery for Bulky Stage I/II Cervical CancerTerminatedNo Results AvailableCervical NeoplasmsDrug: neoadjuvant chemotherapy + radical hysterectomy|Procedure: radical hysterectomyhttps://ClinicalTrials.gov/show/NCT00190528
180594180594A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)Active, not recruitingNo Results AvailableColorectal NeoplasmsDrug: 5FU+l-leucovorin|Drug: UFT+Leucovorinhttps://ClinicalTrials.gov/show/NCT00190515
180595180595Polyclonal Anti-T-Lymphocyte Globulin (ATG) in Type 1 DiabetesRecruitingNo Results AvailableDiabetes Mellitus, Type 1Drug: Polyclonal anti-T-cell antibodieshttps://ClinicalTrials.gov/show/NCT00190502
180596180596A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast CancerCompletedNo Results AvailableBreast Cancer|Neoplasm MetastasisDrug: AC (ADM 40mg/m2+CPA 500mg/m2) q21 days x 6 cycles|Drug: Docetaxel 60mg/m2 every 21 days for 6 cycles|Drug: AC and Docetaxel 60mg/m2 alternately q21 days for 6 cycleshttps://ClinicalTrials.gov/show/NCT00190489
180597180597Elderly NSCLC/D vs DP (JCOG0207)TerminatedNo Results AvailableNon-Small-Cell Lung CancerDrug: Weekly docetaxel alone|Drug: Weekly docetaxel + cisplatin combinationhttps://ClinicalTrials.gov/show/NCT00190476
180598180598Comparison of 2 Antifungal Treatment (Empirical Versus Pre-Empirical) Strategies in Prolonged NeutropeniaTerminatedNo Results AvailableMalignant Hemopathy|Duration of Neutropenia Following Chemotherapy > 10 DaysDrug: Amphotericin Bhttps://ClinicalTrials.gov/show/NCT00190463
180599180599MIG-HD: Multicentric Intracerebral Grafting in Huntington's DiseaseRecruitingNo Results AvailableHuntington DiseaseProcedure: graft intracerebral of foetal neuronshttps://ClinicalTrials.gov/show/NCT00190450
180600180600ANTEAB: a Study of Early Antibiotherapy in the ICU Management of Acute Exacerbations of COPDCompletedNo Results AvailableChronic Obstructive Lung Disease (COLD)Drug: Amoxicillin-clavulanichttps://ClinicalTrials.gov/show/NCT00190437

* Görseller ve İçerik tekif hakkına sahip olabilir